<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04687722</url>
  </required_header>
  <id_info>
    <org_study_id>Rec/00835 Iqra Imtiaz</org_study_id>
    <nct_id>NCT04687722</nct_id>
  </id_info>
  <brief_title>High Intensity Aerobic Training on Primary Dysmenorrhea</brief_title>
  <acronym>HIAT</acronym>
  <official_title>Effects of High Intensity Aerobic Training on Primary Dysmenorrhea Among Young Females.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Riphah International University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Riphah International University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Now a days Aerobic Exercise programs has been widely used as non-pharmacological means of&#xD;
      treating pain disorders. This study intends to determine the effects of high intensity&#xD;
      aerobic training on pain intensity, dysmenorrhea symptoms and quality of life of young girls&#xD;
      having primary dysmenorrhea.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a Randomized Control Trial, which will be conducted in Shifa Tameer-e-Millat&#xD;
      University (Department of Rehabilitation Sciences). the calculated Sample size is 24&#xD;
      individuals using Epitool with 95% Confidence Interval (CI) and power 80%. Individual will be&#xD;
      screened out according to inclusion criteria. Individuals will be allocated randomly into two&#xD;
      groups, 12 in High Intensity Aerobic training group and 12 in Low Intensity Aerobic Training&#xD;
      group by sealed envelope method. High Intensity Aerobic Training will be use in experimental&#xD;
      group. Low Intensity Aerobic Training will be used in Control group. Assessment will be done&#xD;
      on baseline day 1 prior to the intervention and after 8 weeks of training.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Actual">May 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Both experimental and control groups will be treated at the same time following their respective protocols.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>This study will be single blinded randomized control trail, participants will be unaware of treatment groups, they will be randomly allocated through sealed envelope method.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric Pain Rating Scale (NPRS)</measure>
    <time_frame>Baseline</time_frame>
    <description>Numeric Pain Rating Scale (NPRS) will be used for measuring pain intensity of all participants by single examiner. Patient verbally select value between (0-10) on the basis of intensity of pain. (0) means No pain and (10) means maximum pain experienced at baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numeric Pain Rating Scale (NPRS)</measure>
    <time_frame>Post 8 weeks</time_frame>
    <description>Numeric Pain Rating Scale (NPRS) will be used for measuring pain intensity of all participants by single examiner. Patient verbally select value between (0-10) on the basis of intensity of pain. (0) means No pain and (10) means maximum pain experienced at baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Menstrual Symptom Questionnaire</measure>
    <time_frame>Baseline</time_frame>
    <description>Menstrual Symptom Questionnaire will be used for measuring the severity of dysmenorrhea symptoms. It consisted of 25 items questions, participants are asked to indicate degree of their symptoms experience.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Menstrual Symptom Questionnaire</measure>
    <time_frame>Post 8 weeks</time_frame>
    <description>Menstrual Symptom Questionnaire will be used for measuring the severity of dysmenorrhea symptoms. It consisted of 25 items questions, participants are asked to indicate degree of their symptoms experience.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>Baseline</time_frame>
    <description>SF-36 questionnaire will be used for assessing the quality of life of all participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>Post 8 weeks</time_frame>
    <description>SF-36 questionnaire will be used for assessing the quality of life of all participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Progesteron level</measure>
    <time_frame>Baseline</time_frame>
    <description>Blood samples will be taken to measure Serum Progesteron level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Progesteron level</measure>
    <time_frame>Post 8 weeks</time_frame>
    <description>Blood samples will be taken to measure Serum Progesteron level</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Primary Dysmenorrhea</condition>
  <arm_group>
    <arm_group_label>High Intensity Aerobic Training Group.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group will receive High Intensity Aerobic Training at 80-90% of Heart Rate Maximum calculated using karvonen rule.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will receive routine low Intensity aerobic Training at 40-60% of Heart Rate Maximum calculated using karvonen rule.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Intensity Aerobic Training.</intervention_name>
    <description>Participants will perform 2-5 minutes of low to moderate intensity warm up exercises and then 20 minutes of high intensity aerobic training at 80-90% of heart rate maximum increased gradually on treadmill and elliptical trainer and then 2-5 minutes of low to moderate intensity cool down exercises.</description>
    <arm_group_label>High Intensity Aerobic Training Group.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low intensity Aerobic Training</intervention_name>
    <description>Participants will perform 2-5 minutes of low to moderate intensity warm up exercises and then 20 minutes of low intensity aerobic training at 40-60% of heart rate maximum increased gradually on elliptical trainer and jogging and then 2-5 minutes of low to moderate intensity cool down exercises.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Unmarried female students.&#xD;
&#xD;
          -  Moderate to severe dysmenorrhea during the last three periods according to the Numeric&#xD;
             Pain Rating Scale.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of known chronic disease (heart disease, kidney, respiratory, asthma,&#xD;
             diabetes, nervous disorders, blood pressure), limitation on sports/physical activities&#xD;
             due to special medical problems.&#xD;
&#xD;
          -  Presence of any disease of reproductive system.&#xD;
&#xD;
          -  Irregular monthly cycle.&#xD;
&#xD;
          -  Use of any particular medications affecting dysmenorrhea before or during the study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only female participants will be recruited in the study.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huma Riaz, PHD*</last_name>
    <role>Principal Investigator</role>
    <affiliation>Riphah International University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shifa Tameer-e-Millat University (Department of Rehabilitation Sciences).</name>
      <address>
        <city>Islamabad</city>
        <state>Fedral</state>
        <zip>44000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <reference>
    <citation>Vaziri F, Hoseini A, Kamali F, Abdali K, Hadianfard M, Sayadi M. Comparing the effects of aerobic and stretching exercises on the intensity of primary dysmenorrhea in the students of universities of bushehr. J Family Reprod Health. 2015 Mar;9(1):23-8.</citation>
    <PMID>25904964</PMID>
  </reference>
  <reference>
    <citation>Ortiz MI, Cortés-Márquez SK, Romero-Quezada LC, Murguía-Cánovas G, Jaramillo-Díaz AP. Effect of a physiotherapy program in women with primary dysmenorrhea. Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:24-9. doi: 10.1016/j.ejogrb.2015.08.008. Epub 2015 Aug 17.</citation>
    <PMID>26319652</PMID>
  </reference>
  <reference>
    <citation>Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006 May 13;332(7550):1134-8. Review.</citation>
    <PMID>16690671</PMID>
  </reference>
  <reference>
    <citation>Kannan P, Claydon LS, Miller D, Chapple CM. Vigorous exercises in the management of primary dysmenorrhea: a feasibility study. Disabil Rehabil. 2015;37(15):1334-9. doi: 10.3109/09638288.2014.962108. Epub 2014 Sep 22.</citation>
    <PMID>25243766</PMID>
  </reference>
  <reference>
    <citation>Dehnavi ZM, Jafarnejad F, Kamali Z. The Effect of aerobic exercise on primary dysmenorrhea: A clinical trial study. J Educ Health Promot. 2018 Jan 10;7:3. doi: 10.4103/jehp.jehp_79_17. eCollection 2018.</citation>
    <PMID>29417063</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>December 25, 2020</study_first_submitted>
  <study_first_submitted_qc>December 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2020</study_first_posted>
  <last_update_submitted>June 11, 2021</last_update_submitted>
  <last_update_submitted_qc>June 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pain</keyword>
  <keyword>Dysmenorrhae symptoms</keyword>
  <keyword>Menstrual Symptom Questionnaire</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dysmenorrhea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

